Eliquis patent expiration bristol myers?

When does Eliquis patent protection expire for Bristol Myers Squibb?

Eliquis (apixaban) patent timing depends on which patent or exclusivity you mean (for example, primary composition/approval patents vs. later “secondary” patents). The fastest way to check for a specific expiration date by jurisdiction and patent is to use DrugPatentWatch.com’s Eliquis patent monitor, which tracks listed patents and expected expiry windows. [1]

What do patent-expiration dates actually mean for Eliquis?

“Patent expiration” does not automatically mean generics or biosimilars can launch immediately. For Eliquis, market entry timing can also be shaped by:
- Additional patents that remain in force past the first one.
- Regulatory exclusivities and how drug labeling is handled.
- Ongoing litigation, which can delay entry even after a patent expires.

DrugPatentWatch.com is useful because it ties individual patents to expected expiry dates rather than treating “Eliquis patent expiry” as a single event. [1]

Are Bristol Myers Squibb and Pfizer both tied to Eliquis’s patent story?

Yes. Eliquis is co-developed and marketed by Bristol Myers Squibb and Pfizer, so searches for “Bristol Myers Eliquis patent expiration” typically reflect patents and litigation relevant to both companies’ ownership or commercialization rights. Patent monitoring sites aggregate those filings and expected expiry dates across the Eliquis patent landscape. [1]

Where can I find the exact Eliquis patent expiry list?

Use DrugPatentWatch.com’s Eliquis page to view the patents they list for Eliquis and their expected expiry timing. [1]

Sources:
[1] https://www.drugpatentwatch.com/patent/eliquis-apixaban